Crestline Management, LP Abiomed Inc Transaction History
Crestline Management, LP
- $1.88 Billion
- Q3 2024
A detailed history of Crestline Management, LP transactions in Abiomed Inc stock. As of the latest transaction made, Crestline Management, LP holds 8,000 shares of ABMD stock, worth $0. This represents 0.24% of its overall portfolio holdings.
Number of Shares
8,000Holding current value
$0% of portfolio
0.24%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ABMD
# of Institutions
12Shares Held
137KCall Options Held
0Put Options Held
0-
Eaton Vance Management Boston, MA127KShares$00.05% of portfolio
-
Corient Capital Partners, LLC Newport Beach, CA5.3KShares$00.1% of portfolio
-
Advisor Partners LLC Walnut Creek, CA1.31KShares$00.02% of portfolio
-
Redpoint Investment Management Pty LTD1.11KShares$00.04% of portfolio
-
Bluestein R H & CO LLC Birmingham, MI1.03KShares$00.02% of portfolio
About ABIOMED INC
- Ticker ABMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 45,460,900
- Description
- Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...